Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis
- 1 January 2008
- journal article
- other
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 14 (1), 59-66
- https://doi.org/10.1177/1352458507082061
Abstract
This study investigated the cerebrospinal fluid (CSF) levels of ferritin, S100B as biomarkers for glial activation and NfHSM135 — a biomarker of axonal damage — in relation to nitric oxide (NO) metabolites: nitrate and nitrite (NOx) during acute multiple sclerosis (MS) relapse. Thirty-four relapsing—remitting MS (RR-MS) patients during acute relapse and 12 controls were enrolled. Patients were assessed on Expanded Disability Status Scale (EDSS) and underwent lumbar puncture within two weeks following relapse. Twenty patients were available for further follow-up and were assessed on EDSS 6—8 weeks since the relapse onset. The CSF NOx ( P < 0.0001), NfHSM135 ( P = 0.01) and S100B ( P = 0.009) but not ferritin ( P > 0.05) were significantly raised in MS group. There was a significant correlation between CSF ferritin and S100B in RR-MS group ( P = 0.004). CSF NOx did not correlate with S100B and ferritin in study groups. RR-MS patients with detectable NfHSM135 levels had higher NOx compared with subjects having undetectable NfHSM135 ( P = 0.03). In the follow-up study, raised baseline levels of NOx ( P = 0.016) or NfHSM135 ( P = 0.04) inversely correlated with the clinical recovery grade expressed as relative EDSS change between baseline and follow-up. In conclusion, NO metabolites were increased and because of their correlation with a biomarker of axonal degeneration (neurofilaments) and a measure for clinical disability (EDSS), relapse-related nitrosative stress is likely to be relevant to the development of sustained disability in an individual patient. Multiple Sclerosis 2008; 14: 59—66. http://msj.sagepub.comKeywords
This publication has 49 references indexed in Scilit:
- Multiple Sclerosis — The Plaque and Its PathogenesisNew England Journal of Medicine, 2006
- Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and lossJournal of the Neurological Sciences, 2005
- CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosisNeurology, 2004
- Axonal degeneration and inflammation in acute optic neuritisJournal of Neurology, Neurosurgery & Psychiatry, 2004
- The role of nitric oxide in multiple sclerosisThe Lancet Neurology, 2002
- Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlationsBrain, 2002
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and NitriteNitric Oxide, 2001
- The cytokine storm in multiple sclerosisMultiple Sclerosis Journal, 1998
- Rating neurologic impairment in multiple sclerosisNeurology, 1983